Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
7.00
-0.46 (-6.17%)
Sep 5, 2025, 1:59 PM - Market open
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $5,040 → $2,640 | Strong Buy | Maintains | $5,040 → $2,640 | +37,614.29% | May 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $3,840 → $5,040 | Strong Buy | Maintains | $3,840 → $5,040 | +71,900.00% | Dec 19, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $28,800 | Buy | Maintains | $28,800 | +411,328.57% | May 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $36,000 → $28,800 | Buy | Maintains | $36,000 → $28,800 | +411,328.57% | Mar 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $61,200 | Buy | Initiates | $61,200 | +874,185.71% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $61,200 | Buy | Initiates | $61,200 | +874,185.71% | Apr 30, 2021 |